ENTA: Are you saying the market is only seeing 34% ($23/$66) of the 1H15 product lunch? I guess the result of the upcoming trials will either increase or decrease that.
your ENTA MC=$1.3B is a very low number. There is no sense for ABBV send royaly checks to ENTA and, potentially in a future, have plenty of problems with another ENTA acquiring company.
But for now, let us watch clinical results as they are coming out.
News 
Market Data 
Discover 
